Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2018 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

Popular science feature article in Aftenposten Viten:Can statistics and mathematics save as many lives as new medicines?

Oslo University Hospital is part of the PERCATHE (Personalised cancer therapies) consortium, aiming to develop new, powerful and frontiers-breaking methods to build an innovative and practicable pipeline for individualised precision treatment of cancer. PERCATHE is one of 14 convergence environments under UiO:Life Science - the largest priority area at UiO.
Consortium members -  OUS and UIO scientists Arnoldo Frigessi, Olav Engebråten,  Vessela Kristensen, Alvaro Köhn Luque and Carl Henrik Gørbitz - have recently published a feature article in the popular science "Knowledge" (Viten) section of the Norwegian major newspaper Aftenposten, entitled "Can statistics and mathematics save as many lives as new medicines?"

A basic study of the cell cycle by mass cytometry, with implications for exclusion of non-single cell events as ion cloud fusions and aggregates.

Idun Dale Rein, first author
Idun Dale Rein, first author

A recent study from the Sections of Core Facilities/Radiation Biology/Tumor Immunology shows that the cell cycle can be completely resolved by mass cytometry, including subdivision of the G1 and G2 phases. Only a few markers are needed, and the remaining >50 parameters are free to measure the expression of other (phospho)proteins of interest. Stratification of cells into different cell cycle phases also made exclusion of non-single cell events possible, solving another problem in mass cytometry.

Meeting in Oslo January 27-28, 2020:The Genetics and Genomics of Cancer

The Genetics and Genomics of Cancer meeting takes place at Holmenkollen Scandic Hotel January 27-28 2020. The meeting is organized by Oslo University Hospital, Faculty of Medicine at UiO, Akershus University Hospital,  Vestre Viken Hospital Trust and National Breast Cancer Network. More than 20 international speakers are confirmed.

Units and subpages

View all subunitsHide all subunits